Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01124279 | Single-dose, Pharmacokinetics of AMG 853 in Healthy Adult Subjects | PHASE1 | COMPLETED | 43 | — | — | May 1, 2010 | Oct 1, 2010 | Jan 7, 2011 | - | — |
| Arm | Type | Description |
|---|---|---|
| AMG 853 | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| AMG 853 | DRUG | Single dose administration of AMG 853 in tablet form to healthy adult subjects |
Inclusion Criteria: * Non-nicotine or tobacco using, healthy male and/or female subjects between 18 and 55 years of age, inclusive, with no history or evidence of clinically relevant medical disorders as determined by the investigator in consultation with the Amgen physician * Females must be of no...